Contact
Please use this form to send email to PR contact of this press release:
ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10
TO:
Please use this form to send email to PR contact of this press release:
ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10
TO: